David Au, MD, MS- The University of Washington/VA Puget Sound

Shannon Carson, MD, MS- The University of North Carolina

Jerry Krishnan, MD, PhD-The University of Illinois

Todd Lee, PharmD, PhD- The University of Illinois

Peter Lindenauer, MD, MSc- Baystate Health

Mary Ann McBurnie, PhD- Kaiser Permanente Center for Health Research

Richard Mularski, MD, MCR, MSHS- Kaiser Permanente Northwest

William Vollmer, PhD- Kaiser Permanente Center for Health Research

David Au, MD, MS (The University of Washington/VA Puget Sound)- Dr. Au is an Associate Professor of Medicine and Pharmacy and an Investigator within the Department of Veterans Affairs Northwest Center of Excellence for Health Services Research and Development. Dr. Au also co-directs the Clinical Research Training Track within the Division of Pulmonary and Critical Care Medicine at the University of Washington. Dr. Au is nationally recognized for expertise in health services research, clinical and pharmaco-epidemiology of COPD. As a member of the Measurement Assessment Team for COPD, Dr. Au helps develop performance measures for the National Center for Quality Assurance. Dr. Au is the chair of the ATS Behavioral Sciences Assembly (BSA) and is the past chair of both the planning committee and program committees for the BSA. Dr. Au's research program has focused on the co-management of COPD and other common co-existing illnesses such as myocardial infarction, lung cancer, diabetes, hypertension and chronic heart failure. Dr. Au has recently completed an intervention trial to improve the quality of end-of-life communication between clinicians and patients with COPD and is the Principal Investigator of a VA Merit Review to examine the effects variation in lung cancer care on outcomes such as mortality. He leads other studies funded by the American Lung Association (ALA) and NHLBI.     View Biosketch

Shannon S. Carson, MD (The University of North Carolina)- Dr. Carson is Associate Professor of Medicine, Associate Director for the Medical Intensive Care Unit, and Director of the Fellowship Training Program at the University of North Carolina School of Medicine. Dr. Carson is an internationally known expert in the field of respiratory failure and prolonged mechanical ventilation and has published extensively on outcomes and economic issues associated with these conditions. Dr. Carson has conducted comparative effectiveness studies relating to sedation regimens and delirium interventions for mechanically ventilated patients. Dr. Carson has served on the Program Committee and the Planning Committee for the Critical Care Assembly in the ATS and also serves on the Program Committee for the ATS Behavioral Science Assembly. He also serves on the Editorial Board for Chest, one of the primary subspecialty journals for the field of pulmonary and critical care medicine.    View Biosketch

Jerry A. Krishnan, MD, PhD (The University of Illinois) - Dr. Krishnan is Professor of Medicine and Public Health, Associate Vice President for Population Health Sciences, at the University of Illinois Hospital and Health Sciences System. Dr. Krishnan is an expert in clinical investigation in asthma and chronic obstructive pulmonary disease (COPD). Dr. Krishnan is the Chair of the Steering Committee for the COPD Outcomes-base fectiveness and Research Translation (CONCERT), which is funded by AHRQ to develop a national, stakeholder-supported research agenda and by NHLBI to develop a national research infrastructure for effectiveness/implementation studies in COPD. He is a Principal Investigator in NHLBI-sponsored AsthmaNet, a multicenter national network for efficacy studies in asthma, and in AHRQ-sponsored CERT and DEcIDE programs. He is Chair of the FDA Pulmonary and Allergy Drugs Advisory Committee and Chair of the DSMB/OSMB of the NCRR-funded RCMI Translational Research Network.)  View Biosketch

Todd A. Lee, PharmD, PhD (The University of Illinois)– Dr. Lee is a senior investigator in the Center for Management of Complex Chronic Care (CMC3) at the Hines VA Hospital, which is one of 14 VA Centers of Excellence for health services research. He is also an Associate Professor in the Departments of Pharmacy Practice and School of Public Health and Assistant Director of the Center for Pharmacoeconomic Research in the College of Pharmacy at the University of Illinois at Chicago. Dr. Lee’s research focuses on comparative effectiveness of medication therapies in patients with respiratory disease with interest in both safety related issues (pharmacoepidemiology) and costs associated with medication use (pharmacoeconomics) and the intersection of the two disciplines. In addition, he conducts studies of patient outcomes amongst those with co-occurring multiple chronic conditions and the delivery of care to these patients.

Peter K. Lindenauer, MD, MSc, FACP (Baystate Health)- Dr. Lindenauer is Director of the Center for Quality of Care Research at Baystate Medical Center, Medical Director of Clinical Decision Support and Quality Informatics for Baystate Health, and Associate Professor of Medicine at the Tufts University School of Medicine. Dr. Lindenauer's research focuses on the development of methods to measure the quality and outcomes of health care, and the design, and study of interventions to improve care delivery. He is nationally recognized for his use of large administrative datasets to measure the quality of care for patients with pneumonia and COPD, for studies of beta blocker and lipid lowering therapy in patients undergoing surgery, and for his evaluations of the impact of hospitalists and financial incentives in hospital quality. His work has been published in The New England Journal of Medicine, JAMA, Health Affairs, and elsewhere. In 2008 he received the Excellence in Research award from the Society of Hospital Medicine. Dr Lindenauer has played an active role in numerous national quality and safety efforts. He has served as a member of technical expert panels for the National Quality Forum, the National Surgical Care Improvement Project and CMS’s Medicare Patient Safety Monitoring System. He is an advisor to AHRQ’s Web M&M (the online journal of patient safety), is a member of the Editorial Board of the Journal of Hospital Medicine and the Joint Commission Journal of Quality and Patient Safety.

Richard Mularski, MD, MSHS, MCR (Kaiser Permanente Northwest)- Dr. Mularski is an academic physician boarded in pulmonary, critical care, and palliative medicine who leads health services research at The Center for Health Research, Kaiser Permanente and OHSU in Portland, Oregon. He has expertise in research methodology, quality measurement, quality improvement, translational medicine, and implementation of evidence-based medicine in the areas of obstructive lung disease, dyspnea, and palliative & end-of-life care. He has performed evidence-based reviews and performance measure development for AHRQ, DECiDE network, NCI, NQF, and NINR. He led the RAND Health pulmonary quality review for the QA Tools project, is lead author on a consensus statement for 18 proposed quality measures for palliative and end-of-life care for the critically ill hospitalized patient, and serves on the AMA, Physician Consortium for Performance Improvement as the Voting Representative for ATS. His active investigations include a RCT of mind-body breathing therapy to improve palliation of dyspnea and health-related quality of life in COPD, an AHRQ grant to automate asthma quality measurement, PI for the Kaiser site of the IBV Valve Trial, co-Investigator for the NHLBI Long-term Oxygen Treatment Trial (LOTT), as well as other studies. He is active on national policy and professional organization committees – within the ATS, he serves as the Chair for the Quality Improvement Committee and is leading a Workshop report on Dyspnea Crisis as well as prior work on the Health Care Policy Committee, the Executive Committee on Quality Improvement & Safety, the Clinical Practice Committee, and the End-of-Life Care Task Force; for the ACCP he serves on the Clinical Consensus Panel–Management of Dyspnea in Advanced Lung Disease and the Steering Committee–Palliative and End-of-Life Care NetWork. He is the recipient of the 2008 Roger C. Bone Award for Advances In End-of-Life Care awarded by the CHEST Foundation.     View Biosketch

MaryAnn McBurnie, PhD (Kaiser Permanente Center for Health Research)- Dr. McBurnie is an Investigator at the Kaiser Permanente Center for Health Research, Portland, OR. She received her PhD in Biostatistics from the University of Washington, Seattle, WA and has substantial experience in the design, implementation, management, analysis, and dissemination of multi-center clinical trials and epidemiologic studies. She served as a biostatistician for the Cardiovascular Health Study (CHS) Coordinating Center and as the project director for the Coordinating Center of the North American, multi-center Public Access Defibrillation (PAD) Trial. Since joining CHR in 2005, her research has focused on the epidemiology of asthma and COPD and on developing and evaluating methods that rely on electronic medical record (EMR) data for identifying and tracking asthma and COPD patients and for assessing quality of care. Currently, Dr. McBurnie directs the Coordinating Center that supports the six CONCERT Clinical Sites, serves as Project Director for an international study on worldwide variation in COPD (BOLD) and develops methods and directs analyses on several studies that use EMR data to assess quality of medical care provided to patients with asthma, obesity, heart disease, HIV and cancer.    View Biosketch

William M. Vollmer, PhD (Kaiser Permanente Center for Health Research)- Dr. Vollmer is a Senior Investigator at the Kaiser Permanente Center for Health Research in Portland, Oregon. A statistician by training, Dr. Vollmer has been conducting health services research related to obstructive lung disease dating for over 20 years and is an internationally recognized expert in this area. At present he directs the Operations Center for the International Burden of Obstructive Lung Disease (BOLD) study, which thus far has conducted prevalence surveys of COPD in 15 countries around the world. Other pertinent recent and ongoing work include a study of the impact of regular use of inhaled corticosteroids on outcomes in patients with COPD and a randomized trial to improve adherence to inhaled steroids among Kaiser Permanente members. Dr. Vollmer is an active member of the ATS Behavioral Science Assembly, and is a past president of the Oregon Chapter of the American Statistical Association. Dr. Vollmer also has extensive experience in data management and quality control, having served as PI or Project Director of numerous coordinating centers for large, and multi-site collaborative trials.